Fidelity Disruptive Medicine ETF (FMED)

FMED Holdings Information

FMED is an equity ETF with a total of 71 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 5.45%, Boston Scientific at 5.26%, argenx SE at 4.22%, Insulet at 3.75%, and UCB SA at 3.48%.

• Total Holdings: 71
• Top 10 Percentage: 37.99%
• Asset Class: Equity
• ETF Category: Health
• Assets: 54.44M
• PE Ratio: 40.81

Top 25 Holdings

As of Sep 12, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	5.45%	6,399
2	BSX	Boston Scientific Corporation	5.26%	28,000
3	ARGX	argenx SE	4.22%	3,053
4	PODD	Insulet Corporation	3.75%	6,000
5	EBR: UCB	UCB SA	3.48%	7,814
6	VEEV	Veeva Systems Inc.	3.42%	6,764
7	DHR	Danaher Corporation	3.20%	9,208
8	PEN	Penumbra, Inc.	3.12%	6,264
9	n/a	Fidelity Securities Lending Cash Central Fund	3.05%	1,670,717
10	EXAS	Exact Sciences Corporation	3.05%	30,936
11	WAY	Waystar Holding Corp.	3.04%	44,560
12	ISRG	Intuitive Surgical, Inc.	2.63%	3,200
13	LEGN	Legend Biotech Corporation	2.57%	42,453
14	EW	Edwards Lifesciences Corporation	2.42%	17,093
15	MASI	Masimo Corporation	2.29%	8,500
16	SYK	Stryker Corporation	2.10%	3,000
17	EPA: DIM	Sartorius Stedim Biotech S.A.	1.89%	5,191
18	LFST	LifeStance Health Group, Inc.	1.86%	194,725
19	UNH	UnitedHealth Group Incorporated	1.80%	2,800
20	MRUS	Merus N.V.	1.78%	14,000
21	LLY	Eli Lilly and Company	1.78%	1,286
22	TMO	Thermo Fisher Scientific Inc.	1.68%	1,917
23	DXCM	DexCom, Inc.	1.67%	12,000
24	DOCS	Doximity, Inc.	1.65%	12,688
25	RMD	ResMed Inc.	1.59%	3,226

Showing 25 of 71 holdings

Subscribe to see the full list